4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
4.640
-0.030 (-0.64%)
At close: Feb 21, 2025, 4:00 PM
4.870
+0.230 (4.96%)
After-hours: Feb 21, 2025, 5:44 PM EST
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $214.50 million as of February 21, 2025. Its market cap has decreased by -84.89% in one year.
Market Cap
214.50M
Enterprise Value
-311.34M
1-Year Change
-84.89%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $214.50M, a decrease of -63.04%. That is a compound annual growth rate of -21.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 214.50M | -16.70% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |